Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL197887

CCCCC(CC)CNC(CC)CC.N

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.61
ALDH1A1 P00352 5/20 0.61
CYP3A4 P08684 5/20 0.61
TDP1 Q9NUW8 2/20 0.46
KDM4E B2RXH2 1/20 0.40
CA2 P00918 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
HTT P42858 3/20 0.36
GLA P06280 1/20 0.36
ATM Q13315 1/20 0.35
LMNA P02545 3/20 0.34
MEN1 O00255 2/20 0.34
USP2 O75604 2/20 0.34
TP53 P04637 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HIF1A Q16665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL197886 0.84 CYP3A4 (0.53) TSHRALDH1A1CYP3A4TDP1KDM4E
SCHEMBL16390075 0.81 TSHR (0.59) TSHRALDH1A1CYP3A4TDP1KDM4E
SCHEMBL3838045 0.80 TSHR (0.64) TSHRALDH1A1CYP3A4TDP1KDM4E
SCHEMBL15418382 0.79 ALDH1A1 (0.52) TSHRALDH1A1CYP3A4TDP1KDM4E
SCHEMBL3877285 0.77 CYP3A4 (0.59) TSHRALDH1A1CYP3A4TDP1KDM4E
SCHEMBL4162585 0.77 TSHR (0.59) TSHRALDH1A1CYP3A4TDP1KDM4E
SCHEMBL172603 0.77 ALDH1A1 (0.59) TSHRALDH1A1CYP3A4TDP1KDM4E
SCHEMBL9759802 0.77 CYP3A4 (0.59) TSHRALDH1A1CYP3A4TDP1KDM4E
SCHEMBL23611735 0.77 TSHR (1.00) TSHRALDH1A1CYP3A4TDP1KDM4E
SCHEMBL14365914 0.77 TSHR (1.00) TSHRALDH1A1CYP3A4TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3642253-B1 BLOCKING AGENTS FOR AMINES, LATENT CURING AGENTS AND POLYURETHANE COMPOSITIONS SIKA TECH AG (CH) 2023-05-10 EP disclosed
US-11518736-B2 Blocking agent for amines, latent hardeners and polyurethane compositions SIKA TECHNOLOGY AG (CH) 2022-12-06 US disclosed
EP-3394132-B1 TWO-COMPONENT POLYURETHANE COMPOSITION SIKA TECH AG (CH) 2022-11-09 EP disclosed
EP-3394139-B1 POLYURETHANE COMPOSITION WITH LOW PLASTICIZER MIGRATION SIKA TECH AG (CH) 2022-07-20 EP disclosed
US-20220144746-A1 PROCESS FOR PRODUCING 2,2-DIALKYL-3-ACYLOXYPROPANALS SIKA TECHNOLOGY AG (CH) 2022-05-12 US disclosed
US-11214706-B2 Polyurethane composition with low plasticiser migration SIKA TECHNOLOGY AG (CH) 2022-01-04 US disclosed
US-11161930-B2 Two component polyurethane composition SIKA TECHNOLOGY AG (CH) 2021-11-02 US disclosed
US-20210246101-A1 BLOCKING AGENT FOR AMINES, LATENT HARDENERS AND POLYURETHANE COMPOSITIONS SIKA TECHNOLOGY AG (CH) 2021-08-12 US disclosed
US-10442956-B2 Solvent-free polyurethane liquid membrane SIKA TECHNOLOGY AG (CH) 2019-10-15 US disclosed
US-20180371148-A1 TWO COMPONENT POLYURETHANE COMPOSITION SIKA TECHNOLOGY AG (CH) 2018-12-27 US disclosed
US-20100130674-A1 METHOD FOR THE PRODUCTION OF POLYURETHANE COMPOSITIONS WITH A LOW ISOCYANATE MONOMER CONTENT SIKA TECHNOLOGY AG (CH) 2010-05-27 US disclosed
US-20100101455-A1 ALDIMINES AND COMPOSITIONS COMPRISING ALDIMINE SIKA TECHNOLOGY AG (CH) 2010-04-29 US disclosed
US-20100006221-A1 Amorphous polyurethane polymer and its use in hotmelt adhesives SIKA TECHNOLOGY AG (CH) 2010-01-14 US disclosed
US-20100003526-A1 Polyurethane composition with good initial strength SIKA TECHNOLOGY AG (CH) 2010-01-07 US disclosed
US-7629433-B2 Odor-less during hydrolytic deblocking, separation; for use as source for aldehydes; crosslinking agents SIKA TECHNOLOGY AG (CH) 2009-12-08 US disclosed
US-20090176944-A1 Aldimines Comprising Reactive Groups Containing Active Hydrogen, and Use Thereof SIKA TECHNOLOGY AG (CH) 2009-07-09 US disclosed
US-20090159204-A1 Moisture-Hardened Polyurethane Compositions Containing Compounds Comprising Aldimine SIKA TECHNOLOGY AG 2009-06-25 US disclosed
US-20090099333-A1 Compounds Containing Aldimine SIKA TECHNOLOGY AG (CH) 2009-04-16 US disclosed
US-20080280145-A1 moisture-reactive hot-melt adhesive which comprises at least one aldimine and at least one polyurethane polymer ( polyesterurethane copolymer, polyetherurethane copolymer)which contains isocyanate groups and is solid at room temperature; bonded assembly is notable for improved adhesive SIKA TECHNOLOGY AG (CH) 2008-11-13 US disclosed
US-20080251204-A1 Reactive Polyurethane-Hot Melt Adhesive Having a Low Isocyanate-Monomer Content SIKA TECHNOLOGY AG (CH) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11518736-B2 Blocking agent for amines, latent hardeners and polyurethane compositions ODC1, KDM2B, ALKBH2 TSHR 4857/4885ALDH1A1 20/4885CYP3A4 3753/4885
US-20100101455-A1 ALDIMINES AND COMPOSITIONS COMPRISING ALDIMINE ALDH7A1, ILK, ALDH3A1 TSHR 4884/4885ALDH1A1 5/4885CYP3A4 2317/4885
US-20090176944-A1 Aldimines Comprising Reactive Groups Containing Active Hydrogen, and Use Thereof ADH5, ADH1C, ADH1A TSHR 4062/4885ALDH1A1 5/4885CYP3A4 329/4885
US-20210246101-A1 BLOCKING AGENT FOR AMINES, LATENT HARDENERS AND POLYURETHANE COMPOSITIONS ODC1, KDM2B, ALKBH2 TSHR 4857/4885ALDH1A1 20/4885CYP3A4 3753/4885
US-20220144746-A1 PROCESS FOR PRODUCING 2,2-DIALKYL-3-ACYLOXYPROPANALS ADCY4, ADCY1, ADCY2 TSHR 3940/4885ALDH1A1 19/4885CYP3A4 2232/4885
US-20090099333-A1 Compounds Containing Aldimine ALDH7A1, ALDH3A1, ALDH1A1 TSHR 4769/4885ALDH1A1 3/4885CYP3A4 348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.